Abstract
Lymphoproliferative disorders comprise of a group of heterogenous diseases characterised by uncontrolled production of lymphocytes.Castleman disease (CD) is one such disease and comprises of a group of rare disorders that involve enlarged lymph nodes and a broad range of inflammatory symptoms and laboratory abnormalities [1]. We came across young girl who presented to us in the out patient department with this disease After ruling out other pathologies and confirming the diagnosis by doing a tissue biopsy the girl was treated surgically and is disease free till date.
Similar content being viewed by others
References
Castleman B, Iverson L, Menendez,VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822-830.
Castleman, B. & Towne, V. W. Case records of the Massachusetts General Hospital: Case No. 40231. N. Engl. J. Med 250, 1001–1005 (1954).
Keller, A. R., Hochholzer, L. & Castleman, B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29, 670–683 (1972).
Kessler, E. Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer 56, 2446–2451 (1985).
van Rhee, F. et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv 4, 6039–6050 (2020).
Williams D.S. Castleman’s disease. J. Insur. Med. N. Y. N. 2013;43(4):256–258. [PubMed] [Google Scholar] [PubMed] [Google Scholar] .
https://www.hemonc.theclinics.com/article/S0889-8588(17)30142-9/fulltext
POEMS syndrome and Castleman’s disease. in: Zimmerman T.M. Kumar S.K. Biology and management of unusual plasma cell dyscrasias. Springer, New York2017: 41-69
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 2016; 91: 220-226
Wang J, Liang LJ, Wang YM, Mei ZY, Liu YZ, Liu LN, Fang BJ, Song YP. [Analysis of the clinicopathologic features as well as diagnosis and treatment of 59 patients with Castleman disease]. Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):666–670. [PMC free article] [PubMed] [Reference list]
van Rhee F, Greenway A, Stone K. Treatment of Idiopathic Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):89–106. [PubMed] [Reference list]
Talat N., Schulte K.M. Castleman’s disease: systematic analysis of 416 patients from the literature. Oncologist. 2011;16(9):1316–1324. [PMC free article] [PubMed] [Google Scholar] [PMC free article] [PubMed] [Google Scholar]
Chronowski G.M., Ha C.S., Wilder R.B., Cabanillas F., Manning J., Cox J.D. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001;92(3):670–676. [PubMed] [Google Scholar]
Iyer S., Bhatti M.I., Halliday M. Castleman’s disease-a case report. Int. J. Surg. Case Rep. 2010;1(3):25–26. [PMC free article] [PubMed] [Google Scholar] [PMC free article] [PubMed] [Google Scholar]
Funding
No funding was obtained.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent
Written informed consent was taken from the patient for publication of this case.
Conflict of interest
No conflict of interest between authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sheth, R.K., Kumar, P., Vishnurag, A. et al. A Googly in the Neck—Castleman Disease. Indian J Otolaryngol Head Neck Surg 76, 1275–1278 (2024). https://doi.org/10.1007/s12070-023-04266-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-023-04266-3